title: [Effect of silibinin on oxidative damage of blood constituents].
abstract: Silibinin (SDH) is a flavonoid with ascertained hepatoprotective effects, which have been partially attributed to its antioxidant properties. Oxidation of blood constituents could have a role in atherogenesis and interfere with the rheologic properties of the blood. In this study we investigated, whether SDH could protect some blood constituents against oxidative modification. In human plasma we measured TBARS and fluorescence generation as indicators of copper or azobis amidinopropane hydrochloride (AAPH) at 760 mm Hg PO2-induced lipid peroxidation. SDH at 50 microM inhibited copper-induced TBARS formation by 25% and fluorescence by 47%. SDH also inhibited AAPH-induced lipid peroxidation, but at 175 microM concentration only. Oxidative modification of albumine was evaluated by fluorescence generation. SDH at 50 microM inhibited copper/hydrogen peroxide fluorescence generation by 54% and at 2.5 microM it inhibited EDTA-Fe (II)/hydrogen peroxide fluorescence generation by 31%. The protection of albumin by SDH was confirmed by SDS-PAGE electrophoresis. Copper-induced red-cell lipid peroxidation was evaluated by TBARS formation. SDH at 250 microM inhibited copper-induced lipid peroxidation and hemolysis by 45% and 94%, respectively. SDH also inhibited hemolysis in red-cell suspensions exposed to hydrogen peroxide, but not lipid peroxidation. Our results show that SDH may protect blood constituents from oxidative damage.
authors.affiliation: Centro de Metabolismo e Endocrinologia, Faculdade de Medicina de Lisboa, Portugal.
authors.forename: P M
authors.initials: PM
authors.lastname: Filipe
authors.forename: A C
authors.initials: AC
authors.lastname: Fernandes
authors.forename: J N
authors.initials: JN
authors.lastname: Silva
authors.forename: J P
authors.initials: JP
authors.lastname: Freitas
authors.forename: C F
authors.initials: CF
authors.lastname: Manso
mesh_terms: D001769:Blood / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D010084:Oxidation-Reduction / Q000187:drug effects*; D010952:Plasma Substitutes / Q000378:metabolism*; D012709:Serum Albumin / Q000378:metabolism; D012838:Silymarin / Q000494:pharmacology*
chemical_list: D010952:Plasma Substitutes; D012709:Serum Albumin; D012838:Silymarin
vernacular_title: Effet de la silibinine sur la lésion oxydante des constituants du sang.